3α,7α-Dihydroxy-N-(2-sulfoethyl)-5β-cholan-24-amide, 98%

cas: 516-35-8 — see every product listed under this CAS number, including other names

3α,7α-Dihydroxy-N-(2-sulfoethyl)-5β-cholan-24-amide, 98% (CAS 516-35-8) is a chemical reagent available from Chemat. Available pack sizes: 5mg, 250mg, 1g, 5g. Offered by: Chemat.

brandChemat
catalog numberCh11D8ZJ-5mg
cas516-35-8
size5mg
availability 10g
Need more information?

Ask us about this product — we're happy to help.

Available pack sizes

brand size price
Chemat 5mg 88.40 Pln
Chemat 250mg 88.40 Pln
Chemat 1g 141.20 Pln
Chemat 5g 237.20 Pln

properties

purity98%
delivery time3 weeks
Structural formula: {0} (CAS {1})

Taurochenodeoxycholic acid is a bile acid taurine conjugate of chenodeoxycholic acid. It has a role as a mouse metabolite and a human metabolite. It is functionally related to a chenodeoxycholic acid. It is a conjugate acid of a taurochenodeoxycholate.

Source: ChEBI

Identity
Molecular formulaC26H45NO6S
Molecular weight499.7 g/mol
IUPAC name2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
InChIKeyBHTRKEVKTKCXOH-BJLOMENOSA-N
SMILESC[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C

Computed by PubChem (NCBI)

Synonyms: TAUROCHENODEOXYCHOLIC ACID, Taurochenodesoxycholic acid, Chenodeoxycholyltaurine, TCDCA, Chenodeoxycholoyltaurine, N-(3alpha,7alpha-dihydroxy-5beta-cholan-24-oyl)-taurine, Chenodeoxycholate, Taurine, Acid, Taurochenodeoxycholic, Taurochenodeoxycholate, Chenyltaurine
Related forms of this compound
2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid C26H45NO6S
2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-2,2,3,4,4-pentadeuterio-3,7-dihydroxy-10,13-dimethyl-1,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid C26H45NO6S
1,1,2,2-tetradeuterio-2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid C26H45NO6S
2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-2,2,4,4-tetradeuterio-3,7-dihydroxy-10,13-dimethyl-3,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid C26H45NO6S
2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-2,2,4,4-tetradeuterio-3,7-dihydroxy-10,13-dimethyl-3,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid C26H45NO6S
Isomers (same molecular formula)
2-[[(4R)-4-[(3R,5R,6S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid C26H45NO6S
2-[[(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid C26H45NO6S
2-[[(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-2,2,4,4-tetradeuterio-3,12-dihydroxy-10,13-dimethyl-3,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid C26H45NO6S

Also listed as

Taurochenodeoxycholic acid, 95% Combi-blocks CAS 516-35-8
Taurochenodeoxycholic Acid Chemat Brand CAS 516-35-8
Taurochenodeoxycholic Acid/ 99.69% (existing batch purity) TargetMol CAS 516-35-8
3α,7α-Dihydroxy-N-(2-sulfoethyl)-5β-cholan-24-amide, 98%, 98% Chemat CAS 516-35-8
Taurochenodeoxycholic acid, 99.90% MedChemExpress CAS 516-35-8
Taurochenodeoxycholic acid (Standard), 99.67% MedChemExpress CAS 516-35-8
Taurochenodeoxycholic acid, 98% Ambeed CAS 516-35-8
2-((R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonic acid, 98% BLDpharm CAS 516-35-8